
|Articles|July 1, 2004
Medicare reimbursement will affect specialty payouts
You most likely are aware that in December 2003, Congress enacted the MMA (Medicare Modernization Act). Since the majority of Medicare's payments for drugs provided in physician's offices (Part B) are for cancer treatment, it's prudent to evaluate how MMA will affect specialty pharmacy reimbursement and provider revenues.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Judi Health, Employers Health team up to launch new PBM solution
2
Growth of GLP-1 therapies has reshaped the market | PBMI 2026
3
Brandon Kessler on pharmacy pricing under CAA 2026 | PBMI 2026
4
Brandon Kessler on advice to employers about meeting their fiduciary responsibility | PBMI 2026
5
























